SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-12-007424
Filing Date
2012-02-13
Accepted
2012-02-13 06:23:48
Documents
1
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR CAPITAL, L.P.HEALTHCOR GROUP, LLCHEALTHCOR HYBRID OFFSHORE GP, LLCHEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P.HEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE MASTER FUND, L.P.HEALTHCOR, L.P.JOSEPH HEALEY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G v302090_13ga.txt SC 13G/A 49298
  Complete submission text file 0001144204-12-007424.txt   51249
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53269 | Film No.: 12595103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019 212-622-7871
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

IRS No.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A